Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Malignant Solid Tumors × SAR125844 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neoplasms 1 Malignant Solid Tumors 1

Interventions

tislelizumab 1 olaparib 1 Topotecan 1 Sirolimus 1 SAR125844 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01391533 2016-04-13

SARMET

Sanofi

Phase 1 Completed

Other solid neoplasm

Malignant Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡